Terumo Corporation

Research Terumo Corporation (TUO0) on Bullrun: market cap EUR 19.47B, P/E 26.4, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 19.47B; P/E is 26.4; dividend yield is 1.3%.

Peer valuation comparison

Latest P/E is 26.4x versus a Healthcare sector median of 24.46x (7.9% above).

Latest dividend yield is 1.25% versus a Healthcare sector median of 2.11% (40.8% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026JPY 1.13TJPY 135.91BJPY 128.89B52.5%92.12JPY 280.49BJPY 379.80BJPY 1.58T
FY2025JPY 1.04TJPY 116.98BJPY 128.44B54.1%78.99JPY 221.87BJPY 174.84BJPY 1.37T
FY2024JPY 921.86BJPY 106.37BJPY 67.56B52.0%71.47JPY 204.88BJPY 231.85BJPY 1.33T
FY2023JPY 820.21BJPY 89.33BJPY 45.36B50.9%59.48JPY 187.32BJPY 231.94BJPY 1.11T
FY2022JPY 703.30BJPY 88.81BJPY 67.36B52.5%58.69JPY 205.25BJPY 226.00BJPY 1.01T

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23EUR 19.47B26.41.2%0.16

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.16 EUR, yield 1.3%.

YearDividends/share
FY20260.08 JPY
FY20250.16 JPY
FY20240.08 JPY

About Terumo Corporation

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Terumo Corporation's market cap?

Terumo Corporation's market capitalization is EUR 19.47B.

What is Terumo Corporation's P/E ratio?

Terumo Corporation's price-to-earnings (P/E) ratio is 26.4.

Does Terumo Corporation pay a dividend?

Terumo Corporation has a dividend yield of 1.3%.

What does Terumo Corporation do?

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies.